Amiloride indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Amiloride}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== MIDAMOR is indicated as adjunctive treatment with thiazide diuretics or other kaliuretic-d...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Amiloride#Adult Indications and Dosage]]
{{Amiloride}}
{{CMG}}; {{AE}} {{SS}}
 
==Indications and Usage==
 
MIDAMOR is indicated as adjunctive treatment with [[thiazide ]][[diuretic]]s or other kaliuretic-[[diuretic]] agents in congestive heart failure or hypertension to:
 
*help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic [[diuretic]]
*prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias.
 
The use of potassium-conserving agents is often unnecessary in patients receiving [[diuretic]]s for uncomplicated essential [[hypertension]] when such patients have a normal diet. MIDAMOR has little additive [[diuretic]] or antihypertensive effect when added to a [[thiazide ]][[diuretic]].
 
MIDAMOR should rarely be used alone. It has weak (compared with thiazides) [[diuretic]] and antihypertensive effects. Used as single agents, potassium sparing [[diuretic]]s, including MIDAMOR, result in an increased risk of [[hyperkalemia]] (approximately 10% with amiloride). MIDAMOR should be used alone only when persistent [[hypokalemia]] has been documented and only with careful titration of the dose and close monitoring of serum electrolytes.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MIDAMOR (AMILORIDE HYDROCHLORIDE) TABLET [PADDOCK LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4cde6e4-12cb-4e30-920f-5b94576b4863 | publisher =  | date =  | accessdate = 26 February 2014 }}</ref>
 
==References==
{{reflist|2}}
 
{{Sodium channel blockers}}
{{Diuretics}}
 
[[Category:Potassium-sparing Diuretics]]
[[Category:Aminopyrazines]]
[[Category:Guanidines]]
[[Category:World Health Organization essential medicines]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 15:28, 21 July 2014